Skip to main content
Clinical Trials/NCT00627614
NCT00627614
Completed
Not Applicable

Identification and Differentiation of Breast Masses by Vibro-Acoustography

Mayo Clinic1 site in 1 country147 target enrollmentMarch 2006
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Mayo Clinic
Enrollment
147
Locations
1
Primary Endpoint
Detection and differentiation of breast masses with an estimated specificity of ≥ 70% using vibro-acoustography (VA) imaging
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

RATIONALE: New diagnostic procedures, such as vibro-acoustography imaging, may be an effective method of diagnosing breast cancer.

PURPOSE: This clinical trial is studying how well vibro-acoustography imaging works in diagnosing breast masses in women with a breast mass or breast cancer.

Detailed Description

OBJECTIVES: * To study in vivo detection of breast masses by vibro-acoustography (VA) imaging. * To evaluate the performance of VA imaging in differentiating between benign and malignant breast masses identified as BI-RADS 4 or 5. OUTLINE: Patients undergo clinical mammography of the breast, followed by vibro-acoustography (VA) imaging using ultrasonography over 90 minutes. Patients may also undergo further imaging using clinical ultrasonography.

Registry
clinicaltrials.gov
Start Date
March 2006
End Date
April 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Azra Alizad

PI

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Detection and differentiation of breast masses with an estimated specificity of ≥ 70% using vibro-acoustography (VA) imaging

Time Frame: 25 minutes for Breast VA imaging

Study Sites (1)

Loading locations...

Similar Trials